Drugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility
|
|
- Hilary Thomas
- 5 years ago
- Views:
Transcription
1 Drugs Affecting the Gastrointestinal System Antacids, Constipation, Increasing gastrointestinal motility
2 Cells of the Gastric Gland parietal cells: produce & secrete HCl primary site of action for many drugs chief cells: secrete pepsinogen [= a proenzyme] pepsinogen acid pepsin[ breaks down proteins] mucoid cells: mucus-secreting cells purpose = protective mucous coat [HCl]
3 Hydrochloric Acid secreted by parietal cells maintains stomach ph at 1 to 4 stimulants to secretion: large, fatty meals excessive amounts of ETOH emotional stress
4 Parietal Cell Stimulation & Secretion Gastric Gland Histamine H-2 Blocker Illustrations from LifeART, MediClip, Williams & Wilkins, a Waverly Company.
5 Vagus Nerve mast cell Histamine from circulation H-2 Blocker Ca++ Ca++ K+ Energy H+/K+ ATPase Pump H+
6 Management Therapy is aimed at Healing the ulcer Preventing recurrence Drug therapy has several major thrusts Raising gastric ph antacids Inhibitors of acid secretion H2 antagonists Proton pump inhibitors Mucosal protection H Pylori eradication The predominant causes of peptic ulcer disease are H pylori infection and use of NSAIDs accounting for 48% and 24% of cases, respectively.
7 Antacids Neutralize gastric ph Largely replaced in recent years by other drugs Used for fast relief of gastric discomfort, often in combination with other therapies Onset: 5-15 minutes Duration: 2 hours must be used repeatedly to reduce acidity
8 Antacids Formulations: chewable tablets, liquids liquids are more effective Formulations of aluminum, magnesium and calcium, often combinations are made
9 MOA Antacids Do nothing to stop overproduction of acid Promote gastric mucosal defenses by: stimulating mucus, prostaglandins, and bicarbonate secretion from the gastric glands
10 Effects of Antacids raising ph 1.3 to 1.6 acid in gastric juices 50% neutralized raising ph 1.3 to 2.3 reduction of acid by 90% reduces pain assoc. with acid-release
11 Therapeutic Uses Heart burn DU GU Doses: 1-2 tablespoon 1-3 hours after meals ( meq)
12 Side Effects Minimal and depend upon compound May be unpleasant or chalky tasting flavors are better tolerated magnesium: Diarrhea, in RF causes CNS toxicity aluminum & calcium constipation
13 Drug Interactions Four basic mechanisms chelation: binding or inactivation of another drug chemical inactivation: produces insoluble complexes increased stomach ph: increases absorption of basic drugs decreases absorption of acidic drugs increased urinary ph increases excretion of acidic drugs decreases excretion of basic drugs
14 Cimetidine Ranitidine Famotidine Nizatidine
15 H 2 Antagonists Histamine type 2 receptor [H 2 ] competitive antagonist prototypical acid secretory antagonists Reduce, but not abolish acid secretion one of most frequently Rx d drugs
16 MOA 2 mechanism: Competitively block the histamine (H 2 ) receptor of acid-producing parietal cells Also up to 90% inhibition of vagal stimulated and gastrin stimulated acid secretion
17 Therapeutic Effects Proven effective: PUD = gastric & duodenal ulcer Gastroesophageal reflux disease [GERD] Upper GI bleed [GIB] May be effective: Prevention of stress ulcers Peptic esophagitis Less potent than PPIs but still suppress acid by 60-70% over 24 hrs Complete inhibition has not been shown.
18 70-85% of patients with DU respond in 4-6 weeks and 87% to 94% after 8 weeks. Suppression of acid secretion during night % of patients with GU respond in 6-8 weeks. It is used in half of usual dose to prevent recurrence of ulcer.
19 Side Effects Cimetidine: Overall low < 3% Headache, dizziness, confusion, rash, liver & kidney impairment, muscle cramp, fever Impotence, increased prolactin, & gynecomastia Dosage: qid or at hs Ranitidine: Headache, arrhythmia, confusion Dosage: bid or at hs
20 Drug Interactions Cimetidine: Decrease the activity of cytochrome P 450 Ranitidine Inhibits CYP 450, 4-10 times less than cimetidine. Concurrent use with omeprazole decreases its effect Cigarette decreases their effects
21 Anticholenergics Clidinium, Dicyclomine, Glycopyrrolate, Propanthelene, Pirenzepine Decreases the effect of Ach on the parietal cells Therapeutic Uses: Not a mainstay of therapy Should not be used in GERD Side effects: Blurred vision, dry mouth, tachycardia, urinary retention, constipation
22 Omeprazole Rabeprazole Pantoprazole Lansoprazole Esomeprazole
23 H + /K + ATPase = site of action Final common step in acid production Vagus Nerve Acetylcholine atropine mast cell Ca++ ATP Histamine H-2 Blocker camp from circulation Ca++ Gastrin K+ Energy H+/K+ ATPase Pump H+
24 MOA Proton Pump Inhibitors convert in to their active form in the acidic environment (Activated only when ph decreases below 4) irreversibly bind to H + /K + ATPase prevent H + ion production & secretion block all acid secretion = achlorhydria to return to normal must synthesize new H + /K + ATPase Delayed effect
25 should be administered approximately 1 hour before a meal have a short serum half-life concentrated and activated near their site of action have a long duration of action.
26 Therapeutic Effects GERD Drug of choice PUD recurrent [Helicobacter pylori] Better than H 2 antagonists Erosive esophagitis Zollinger-Ellison syndrome [ZE] NSAID associated ulcers Prevention of Rebleeding from Peptic Ulcers Prevention of stress related mucosal bleeding
27 Dosage: 20 mg qd for 4-8 weeks Most effective after a prolonged fast when large amounts of active proton pumps are present (i.e. breakfast) PPIs provide superior acid suppression, healing rates, and symptom relief vs H2 blockers and heal 95% of duodenal ulcers and 80% to 90% of gastric ulcers by 4 weeks
28 Side Effects & Interactions Side effects: (mild) nausea, headache, diarrhea, constipation, flatulence, hypergastrinemia ECL hypeplasia May affect absorption of other drug May decrease calcium absorption or osteoclast, which may lead to hip fracture. nosocomial pneumonia
29
30 Sucralfate cytoprotective agent once comes in contact with acid in stomach dissociate into aluminum hydroxide & sulfate anions attracted to and bind to the base of ulcers & erosions forms a protective barrier over the base of this area binds to exposed proteins of ulcers limits pepsin s proteolytic action here
31 Sucralfate Uses: gastric, duodenal and oral ulcers, GI bleed, stress ulcer prevention Minimal absorption Dosing: 1 g qid, 1 hr before meals & hs on empty stomach
32 Side effects: constipation, sleepiness, hypophosphatemia Drug interaction: decreases absorption of many drugs and fat soluble vitamins
33 Bismuth subcitrate Coats ulcer at low ph Assists H Pylori eradication Causes black tongue and stool Must be taken at least half an hour before meals Bismuth based preparations have more adverse effects, and also ~85% success. However cheapest. Bismuth, metronidazole and tetracycline, and a proton pump inhibitor for 2 weeks
34 H Pylori eradication regimens Clarithromycin based quadruple therapy has highest eradication rate (~95%) Omeprazole (any PPI), clarithromycin, amoxicillin and metronidazole, all twice daily for a week Non-clarithromycin based regimens: cheaper, but lower eradication rate (~85%) Omeprazole (or high dose ranitidine), amoxicillin and metronidazole for 2 weeks
35 Eradication of H pylori reduces the incidence of peptic ulcer disease recurrence, from 67% to 6% for DU and from 59% to 4% for GU. Continue PPIs after 6 weeks of triple therapy, especially if ulcer is >1 cm.
36 Laxatives Bulk-formers Osmotic laxatives Stool softeners Stimulant Laxatives
37 Bulk-forming Laxatives Psyllium, bran, etc. Swells in water to form gel that increases bulk and softens stool, increase peristalsis Similar to the action of dietary fiber Useful in chronic constipation, and in irritable bowel syndrome Onset: hrs Powder needs reconstitution in at least 8 oz (1 glass) water or juice Drink 6-8 glasses of water
38 Osmotic laxatives Increase colonic fluid retention Nonabsorbable Stimulate peristalsis Include two types: Nonabsorbable Sugars Nonabsorbable salts
39 Nonabsorbable Sugars Lactulose In the colon hydrolyzes to lactic acid, formic acid, and acetic acid Onset: hr Sorbital Side effects: flatulence, abdominal bloating, diarrhea Polyethylene Glycol - does not produce significant cramps or flatus.
40 Nonabsorbable salts Milk of Magnesia, Magnesium oxide Used in simple constipation & postop Onset: hours Use cautiously in renal impairment Potential for hypermagnesemia due to reduced excretion
41 Stool softeners Docusate, Paraffin (Mineral oil), Glycerin Reduce surface tension in the bowel increasing water absorption into stool Onset: 6-8 hrs Side effects: (rare) GI pain, cramping, rash, decrease absorption of fat soluble vitamins Administer with adequate fluids
42 Stimulant Laxatives May stimulate myenteric plexus Increase intestinal peristaltic motility and secretion Onset: 2-6 hours Potent, may cause watery stools, cramping Often used for preprocedure bowel preps, postop Side effects: abdominal discomfort, nausea, cramps
43 Castor oil Besides irritation, it has surfactant activity It may acts through inhibition of Na + /k + ATPase, camp, PGs
44 Bisacodyl (Dulcolax) inhibition of Na + /k + ATPase, camp, PGs Tablets Onset: 6-12 hrs Suppository Onset: minutes Used in conjunction with PEG
45 Senokot (senna) Natural, obtained from dried cassia leaflets Used for simple constipation, postop, other Onset: 6-12 hours (up to 24)
46 Drugs promoting gastrointestinal motility Time to empty half of liquid is half an hour and to empty solids is 2 hours Factors that delay the gastric emptying: Neuropathy, myopathy, electrolyte disturbances, gastroenteritis, anticholenergics, TCA, levodopa, β agonists Factors that enhance the gastric emptying: Metoclopramide, Cisapride, Domperidone, cholinomimetics
47 Metoclopramide Mechanism: CNS: D 2 antagonist Peripheral: cholinergic agonist, dopamine antagonist, 5-HT 4 agonist, 5-HT 3 blocker, sensitize intestinal smooth muscles to the Ach Increases gastric contractions, gastric emptying and peristaltic movement, raises pressure of lower esophageal sphincter block dopamine D 2 receptors in the CTZ of the medulla, resulting in potent anti N/V
48 Indications: 1. Decreases gastric emptying time 2. GERD 3. Nausea 4. Before induction of anesthesia 5. Facilitates small bowel intubation 6. Increases lactation
49 Side effects Insomnia, fatigue, restlessness, unordinary weakness Galactorrhea, menstrual disorders Extraperimedial side effects: parkinson, dystonic reactions, akatesia, tardive dyskenesia Especially in elders and youngsters
50 Drug Interactions Increases the effect of CNS depressant Increases the EP side effects of haloperidol, phenothiazines, thioxanthins Antimuscarinics neutralize the effects of metoclopramide
51 Other drugs Domperidone Like metoclopramide except it does not enter the CNS Cisapride No effect on DA, activation of 5-HT 4 and Ach Causes fatal ventricular arrhythmia, diarrhea Cholinergic agonists Increase the effect of metoclopramide Erythromycin Prokinetic activity
GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali
GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers
More informationGI Pharmacology. Dr. Alia Shatanawi 5/4/2018
GI Pharmacology Dr. Alia Shatanawi 5/4/2018 Drugs Used in Gastrointestinal Diseases Drugs used in Peptic Ulcer Diseases. Drugs Stimulating Gastrointestinal Motility &Laxatives. Antidiarrheal Agents. Drugs
More informationSecond term/
Second term/ 2015-2016 L. 1 Dr Mohammed AL-Zobaidy Learning objectives GIT pharmacology After completing this chapter the student will be able to: Recognise pathophysiological factors implicated in acid-peptic
More informationA. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer.
Pharmacology - Problem Drill 21: Drugs Used To Treat GI Disorders No. 1 of 10 1. Endogenous secretagogues for stomach acid include: #01 (A) Histamine (B) Gastrin (C) PGE1 (D) A and B (E) A, B and C Histamine
More informationLab:2 Drugs acting on Gastrointestinal tract
Lab:2 Drugs acting on Gastrointestinal tract Drugs that used to treat three common medical conditions involving the gastrointestinal tract: peptic ulcers and gastroesophageal reflux disease (GERD), chemotherapy-induced
More informationCopy right protected Page 1
DRUGS USED IN ULCERS AND GIT DISORDERS A peptic ulcer, also known as PUD or peptic ulcer disease is an ulcer of an area of the gastrointestinal tract that is usually acidic and thus extremely painful.
More informationGI Pharmacology. Dr. Alia Shatanawi 5/4/2018
GI Pharmacology Dr. Alia Shatanawi 5/4/2018 Z Gastroenterol. 1983 Mar;21 Suppl:111-6. [Effect of antacids on intestinal motility]. [Article in German] Wienbeck M, Erckenbrecht J, Strohmeyer G. Abstract
More informationGastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D
Gastro-oesophageal reflux disease and peptic ulcer disease By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease Learning objectives:
More informationPharmacology. Drugs that Affect the Gastrointestinal System
Pharmacology Drugs that Affect the Gastrointestinal System Topics Peptic Ulcer Disease Constipation Diarrhea Emesis Digestion Peptic Ulcer Disease Factors that Increase Acidity Factors that Protect Against
More informationPeptic ulcer disease Disorders of the esophagus
Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Burning epigastric pain Exacerbated by fasting Improved with meals Ulcer: disruption of mucosal integrity >5 mm in size, with depth
More informationChapter 63 Drugs Used in the Treatment of Gastrointestinal Diseases
Chapter 63 Drugs Used in the Treatment of Gastrointestinal Diseases p1009 DRUGS USED IN ACID-PEPTIC DISEASES 1. classification of drugs 2. agents that reduce intragastric acidity Antacids,H 2 antagonists,proton
More information- Ali Yaghi. - Sara Yaghi. - Alia Shatnawi. 1 P a g e
-2 - Ali Yaghi - Sara Yaghi - Alia Shatnawi 1 P a g e We ended the previous lecture with H2 receptor antagonists, which work by selectively inhibiting H2 receptors. They are widely used to treat: 1- GERD,
More informationOSPAP Programme. Gastrointestinal Drugs. Dr. Adrian Moore Dale
PAP Programme Dr. Adrian Moore Dale 1.03 Adrian.Moore@sunderland.ac.uk 0191 5152554 lide 1 of 26 PAP MPM14 Acid-Related Pathophysiology The stomach secretes: ydrochloric acid (Cl) aids digestion and also
More informationEMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated
EMILOK Global (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated granules. Properties: Emilok (omeprazole) belongs to the group of proton pump inhibitors, inhibits both
More information-Mohammad Ashraf. -Anas Raed. -Alia Shatnawi. 1 P a g e
-1 -Mohammad Ashraf -Anas Raed -Alia Shatnawi 1 P a g e Dr. Alia started the lecture by talking about subjects we are going to cover through this course; you can refer to the record if you are interested.
More informationKK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011
KK College of Nursing Peptic Ulcer Badil Dass, Lecturer 25 th July, 2011 Objectives: By the end of this lecture, the students t will be able to: Define peptic pp ulcer Describe the etiology and pathology
More informationAntidiarrheals Antidiarrheal
Antidiarrheals Major factors in diarrhea Increased motility of the GI tract. Decreased absorption of fluid. Antidiarrheal drugs include: Antimotility agents. Adsorbents. Drugs that modify fluid and electrolyte
More informationHelicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.
An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology
More informationThe usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.
Name Gasec - 2 Gastrocaps Composition Gasec-20 Gastrocaps Each Gastrocaps contains: Omeprazole 20 mg (in the form of enteric-coated pellets) Properties, effects Proton Pump Inhibitor Omeprazole belongs
More informationReflux of gastric contents, particularly acid, into the esophagus
Heartburn Reflux of gastric contents, particularly acid, into the esophagus Patient assessment with GERD 1-signs and symptoms The hallmark of typical symptom of GERD is heartburn (restrosternal),acid regurgitation,
More informationDrugs Affecting the Gastrointestinal System. Antidiarrheal and Laxatives
Drugs Affecting the Gastrointestinal System Antidiarrheal and Laxatives Diarrhea Abnormal frequent passage of loose stools or Abnormal passage of stools with increased frequency, fluidity, and weight,
More informationMosby items and derived items 2005, 2002 by Mosby, Inc. 1 Mosby items and derived items 2005, 2002 by Mosby, Inc. 2
CHAPTER 49 Acid-Controlling Agents NDEG 26 A Pharmacology I Eliza Rivera-Mitu, RN, MSN Types of Acid-Controlling Agents Antacids H 2 antagonists Proton pump inhibitors Mosby items and derived items 2005,
More informationHeartburn, also referred to acid reflux, happens when stomach acid flows back (refluxes) into your esophagus.
WHILE almost everyone experiences mild heartburn from time to time and many individuals have some antacids or another medication on hand for its relief, talk to your doctor, if you have heartburn more
More informationGastrointestinal Pharmacology
Gastrointestinal Pharmacology Jan Kehr Department of Physiology and Pharmacology Gastrointestinal Pharmacology v Background v Peptic disorders v Constipation and Diarrhea v Chronic Bowel Disease Gastrointestinal
More informationCase 4: Peptic Ulcer Disease. Requejo, April Salandanan, Geralyn Talingting, Vennessa Tanay, Arvie
Case 4: Peptic Ulcer Disease Requejo, April Salandanan, Geralyn Talingting, Vennessa Tanay, Arvie Case 4: PUD Problem List: 1. Peptic Ulcer Disease SOAP Note: S Patient is complaining of abdominal pain
More informationPharmacology. -Alia Shatnawi
Pharmacology -3 -Alia Shatnawi Gastroesophageal reflux disease (GERD): a digestive disorder that affects the lower esophageal sphincter, characterized by reflux of acids from the stomach to the esophagus
More informationConstipation an Old Friend. Presented by Dr. Keith Harris
Constipation an Old Friend Presented by Dr. Keith Harris Irregularity and the Tricks of the Trade." CONSTIPATION What is constipation? INFREQUENT BOWEL MOVEMENTS DIFFICULTY DURING DEFECATION SENSATION
More informationProtectives and Adsorbents. Inorganic chemistry Course 1 Third year Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry
Protectives and Adsorbents Inorganic chemistry Course 1 Third year 2016-2017 Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry Protectives and Adsorbents This group of gastrointestinal agents
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. lansoprazole delayed-release capsule (Manufacturer s standard)
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr PREVACID lansoprazole delayed-release capsule (Manufacturer s standard) Read this carefully before you start taking
More informationAntacid therapy: Antacids side effects:
Antacids Lec:5 When the general public ask why it takes antacids, the answer will include: 1.that uncomfortable feeling from overeating. 2. heart burn. 3. a growing hungry feeling between meals. Antacids
More informationModule 2 Heartburn Glossary
Absorption Antacids Antibiotic Module 2 Heartburn Glossary Barrett s oesophagus Bloating Body mass index Burping Chief cells Colon Digestion Endoscopy Enteroendocrine cells Epiglottis Epithelium Absorption
More informationPolicy Evaluation: Proton Pump Inhibitors (PPIs)
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More information2.08 Understand the functions and disorders of the digestive system Essential questions
2.08 Understand the functions and disorders of the digestive system Essential questions What are the functions of the digestive system? How do the functions of chemical and physical digestion interrelate?
More informationUniversity of Buea. Faculty of Health Sciences. Programme in Medicine
Faculty of Health Sciences University of Buea Wednesday, 28 th January 2009 Time: 8 00-10 00 Programme in Medicine MED 303 (Gastrointestinal Physiology) EXAMS (2008-2009) Identify the letter of the choice
More informationMEDICATION GUIDE Lansoprazole Delayed-Release Capsules, USP
MEDICATION GUIDE Lansoprazole Delayed-Release Capsules, USP Read this Medication Guide before you start taking lansoprazole delayed-release capsules and each time you get a refill. There may be new information.
More informationDRUGS AFFECTING THE GASTROINTESTINAL SYSTEM
Page 1 DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM SUNALI MEHTA Histamines and antihistamines: Histamine means tissue amine and is present in ample amount in the lung, skin and GI tract mucosa. Mast cells,
More informationDrug Class Monograph
Drug Class Monograph Class: Proton Pump Inhibitors Drugs: Aciphex Sprinkle (rabeprazole), Dexilant (dexlansoprazole), Lansoprazole, Nexium (esomeprazole capsule, esomeprazole granules), Omeprazole, Pantoprazole,
More informationProton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.09.01 Subject: Proton Pump Inhibitors Page: 1 of 7 Last Review Date: June 12, 2014 Proton Pump Inhibitors
More informationINFORMATION FOR THE CONSUMER
INFORMATION FOR THE CONSUMER IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT NAT-Omeprazole DR (omeprazole magnesium delayed release tablets) Read this leaflet carefully. It contains general points about NAT-Omeprazole
More information* Adults. NSAID associated peptic ulceration: - Acute treatment: 150 mg twice daily for 8 to 12 weeks, or 300mg nocte.
Trade Name Aciloc 75 mg & 300 mg Film-coated tablets Generic Name Ranitidine Composition Each Aciloc 300 mg film-coated tablet contains: - Active ingredient: Ranitidine hydrochloride 336 mg equivalent
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. OMEPRAZOLE Omeprazole Delayed-Release Capsules
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr OMEPRAZOLE Omeprazole Delayed-Release Capsules Read this carefully before you start taking OMEPRAZOLE and each time
More informationConstipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment
CONSTIPATION Constipation An Overview Definition Physiology of GI tract Etiology Assessment Treatment Definition Constipation = the infrequent passage of hard feces Definition of Infrequent The meaning
More informationOptimal Drugs for ICU Stress Ulcer Prophylaxis: Other. Grand Rounds Monday August 9, 2010 Teresa Jones R2
Optimal Drugs for ICU Stress Ulcer Prophylaxis: Other Grand Rounds Monday August 9, 2010 Teresa Jones R2 Outline Options besides PPIs Comparison to PPIs Negative Effects of PPIs Conclusion Do we really
More informationPHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE
PHARMACOLOGY OF GASTROINTESTINAL TRACT TREATMENT OF ULCER DISEASE Definition A circumscribed ulceration of the gastrointestinal mucosa occurring in areas exposed to acid and pepsin and most often caused
More informationUPPER GI DISEASES 11/15/2014. Lesson Objectives. GI Tract Review. NUTR 2050 Nutrition for Nursing Professionals. Mrs. Deborah A. Hutcheon, MS, RD, LD
UPPER GI DISEASES NUTR 2050 Nutrition for Nursing Professionals Mrs. Deborah A. Hutcheon, MS, RD, LD Lesson Objectives At the end of the lesson, the student will be able to: 1. Describe causes and contributing
More information.Drugs and the gastrointestinal system. Control of gastric acid secretion Gastric acid-related conditions. Clinical sketch.
.Drugs and the gastrointestinal system Chapter 11 11.1 Gastric acid-related conditions 149 11.2 Nausea and vomiting 153 11.3 Disorders of the bowel 155 11.4 Gallstones 156 Self-assessment on Chapter 11:
More informationOverview of digestion or, gut reactions - to food
Key concepts in Digestion. Indigestion module Overview of digestion or, gut reactions - to food Prof. Barry Campbell Gastroenterology Cellular & Molecular Physiology e-mail: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl
More informationRABEPRAZOL 10mg and 20mg Gastro-resistant Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
More informationCHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS. 1. Which of the following is not a common cause of peptic ulcer disease (PUD)?
CHAPTER 18. PEPTIC ULCER DISEASE, SELF-ASSESSMENT QUESTIONS 1. Which of the following is not a common cause of peptic ulcer disease (PUD)? A. Chronic alcohol ingestion B. Nonsteroidal antiinflammatory
More informationPthaigastro.org. Evolution of antisecretory agents. History. Antacids and anticholinergic drugs
Evolution of antisecretory agents uthapong Ukarapol, MD. Division of Gastroenterology Chiang Mai University istory 1823- Prout discovered gastric hydrochloric acid 1875- eidenhain and 1893- Golgi identified
More informationUnderstanding your take home medications from the surgical ward. Information for Patients
Understanding your take home medications from the surgical ward Information for Patients i Information for Patients Please read this leaflet before taking the medications that have been prescribed for
More informationSUCRALFATE TABLETS, USP
1234567890 10 210002 SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. It has the following structural formula:
More informationLESSON ASSIGNMENT. After completing this lesson, you should be able to:
LESSON ASSIGNMENT LESSON 4 Cathartics. LESSON ASSIGNMENT Paragraphs 4-1 through 4-10. LESSON OBJECTIVES After completing this lesson, you should be able to: 4-1. Given a group of statements, select the
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. OMEPRAZOLE Omeprazole Delayed-Release Capsules
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION OMEPRAZOLE Omeprazole Delayed-Release Capsules Read this carefully before you start taking OMEPRAZOLE and each time
More informationProton Pump Inhibitors. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.01 Subject: Proton Pump Inhibitors Page: 1 of 6 Last Review Date: June 24, 2015 Proton Pump Inhibitors
More informationOverview of digestion or, gut reactions - to food
1 Key concepts in Digestion. Indigestion module Overview of digestion or, gut reactions to food Prof. Barry Campbell Gastroenterology Cellular & Molecular Physiology email: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl
More informationA SLP s Guide to Medication Therapy and Management. Sarah Luby, PharmD, BCPS KSHA 2017
A SLP s Guide to Medication Therapy and Management Sarah Luby, PharmD, BCPS KSHA 2017 Objectives Identify the appropriate route of administration for medications and proper formulations for use Understand
More informationSUCRALFATE TABLETS, USP
1234567890 10 210002-01 SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. It has the following structural formula:
More informationPeptic Ulcer Disease: Zollinger-Ellison Syndrome
GASTROINTESTINAL PHYSIOLOGY 235 Case 41 Peptic Ulcer Disease: Zollinger-Ellison Syndrome Abe Rosenfeld, who is 47 years old, owns a house painting business with his brothers. The brothers pride themselves
More informationMEDICATION GUIDE. PREVACID can have other serious side effects. See What are the possible side effects of PREVACID?
Page 33 of 39 MEDICATION GUIDE PREVACID (prev-a-sid) (lansoprazole) Delayed-Release Capsules and PREVACID SoluTab (prev-a-sid sol-u-tab) (lansoprazole) Delayed-Release Orally Disintegrating Tablets Read
More informationNational Digestive Diseases Information Clearinghouse
Gastritis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is gastritis? Gastritis is a condition in which the stomach
More informationMedication Guide Lansoprazole Delayed-Release Capsules, USP (lanz-ah-pray-zol)
Medication Guide Lansoprazole Delayed-Release Capsules, USP (lanz-ah-pray-zol) Read this Medication Guide before you start taking lansoprazole delayed-release capsules and each time you get a refill. There
More informationPPIs: Good or Bad? 1. Basics of PPIs. Gastric Acid Basics. Outline. Gastric Acid Basics. Proton Pump Inhibitors (PPI)
Outline Quick basics on Proton Pump Inhibitors (PPIs) PPIs: Good or Bad? What are potential risks of PPI therapy? How to approach your patients American Gastroenterology Association (AGA) recommendations
More informationGASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA
GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA MANAGEMENT Dyspepsia refers to a spectrum of usually intermittent upper gastrointestinal symptoms, including epigastric pain and heartburn. For the majority
More informationPeptic Ulcer Disease Update
Peptic Ulcer Disease Update Col Pat Storms RAM 2005 Disclosure Information 84th Annual AsMA Scientific Meeting Col Patrick Storms I have no financial relationships to disclose. I will discuss the following
More informationProton Pump Inhibitors (PPIs) (Sherwood Employer Group)
Proton Pump Inhibitors (PPIs) (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf
More informationProton Pump Inhibitors Drug Class Prior Authorization Protocol
Proton Pump Inhibitors Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: November 15, 2017 Effective Date: January 1, 2018 This policy has been developed through review
More informationMEDICATION GUIDE. Rabeprazole Sodium Delayed-Release Tablets Rx Only
MEDICATION GUIDE Rabeprazole Sodium Delayed-Release Tablets Rx Only Read the Medication Guide that comes with rabeprazole sodium delayed-release tablets before you start taking it and each time you get
More informationGASTROINTESTINAL MEDICATIONS By: Jerald S. Ugdoracion, RN, MN-MS
GASTROINTESTINAL MEDICATIONS By: Jerald S. Ugdoracion, RN, MN-MS Reviewing these things may help you in understanding better how gastrointestinal medications alleviate problems of the GI tract: a. Review
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. lansoprazole delayed-release tablet
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr PREVACID FasTab lansoprazole delayed-release tablet Read this carefully before you start taking PREVACID FasTab and
More informationGastric and Intestinal secretion
Gastric and Intestinal secretion OBJECTIVES: 1. Describe the various types of gastric cells and the secretion of each cell type. 2. Mention the components of gastric juice and the function of each component.
More informationGI Pharmacology. Dr. Alia Shatanawi
GI Pharmacology Dr. Alia Shatanawi 10-04-2018 GastroEsophageal Reflux Disease GastroEsophageal Reflux Disease Heartburn; Dysphagia; chronic symptoms or mucosal damage produced by abnormal reflux of gastric
More informationOur gut reactions to food or, gut reactions - to food
Key concepts in Digestion. Our gut reactions to food or, gut reactions to food Prof. Barry Campbell Cellular & Molecular Physiology email: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl Swallowing
More informationMANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Routine endoscopic investigation of patients of any age, presenting with dyspepsia
More informationThe Aging Digestive System
The Aging Digestive System shows significant senescence in old age: less saliva food less flavorful, harder swallowing ~half of those over 65 yrs wear dentures gastric mucosa secretes less acid reduces
More information5. Which component of the duodenal contents entering the stomach causes the most severe changes to gastric mucosa:
Gastro-intestinal disorders 1. Which are the most common causes of chronic gastritis? 1. Toxic substances 2. Chronic stress 3. Alimentary factors 4. Endogenous noxious stimuli 5. Genetic factors 2. Chronic
More informationEsomeprazole strontium can have other serious side effects. See What are the possible side effects of esomeprazole strontium?
MEDICATION GUIDE ESOMEPRAZOLE STRONTIUM (es-o-mep-ra-zol stron-tee-um) delayed-release capsules Read the Medication Guide that comes with esomeprazole strontium before you start taking esomeprazole strontium
More informationRpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives
Esomeprazole 20mg Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (8886Q) (029W) Gastric ulcer Peptic ulcer Treatment Phase: Initial treatment The therapy must be for initial treatment
More informationNausea and Vomiting in Palliative Care
Nausea and Vomiting in Palliative Care Definitions Nausea - an unpleasant feeling of the need to vomit Vomiting - the expulsion of gastric contents through the mouth, caused by forceful and sustained contraction
More informationSoft palate elevates, closing off the nasopharynx. Hard palate Tongue Bolus Epiglottis. Glottis Larynx moves up and forward.
The Cephalic Phase Chemical and mechanical digestion begins in the mouth Saliva is an exocrine secretion Salivary secretion is under autonomic control Softens and lubricates food Chemical digestion: salivary
More informationZantac for stomach ulcers
P ford residence southampton, ny Zantac for stomach ulcers Information on the drug ranitidine (Zantac) used in and duodenal ulcers, heartburn, esophagitis, and Zollinger Ellison Syndrome. Side. But with
More informationPREVACID is used in children and adolescents (ages 1 to 17): for up to 12 weeks to treat GERD and erosive esophagitis in children 1 to 11 years old.
MEDICATION GUIDE PREVACID (prev-a-sid) Delayed-Release Capsules and PREVACID SoluTab (prev-a-sid sol-u-tab) Delayed-Release Orally Disintegrating Tablets Read this Medication Guide before you start taking
More informationFecal incontinence causes 196 epidemiology 8 treatment 196
Subject Index Achalasia course 93 differential diagnosis 93 esophageal dysphagia 92 95 etiology 92, 93 treatment 93 95 work-up 93 Aminosalicylates, pharmacokinetics and aging effects 36 Antibiotics diarrhea
More informationGastroesophageal Reflux Disease (GERD)
Gastroesophageal Reflux Disease (GERD) Information for patients UHN Read this handout to learn about: What gastroesohageal reflux (GERD) is Signs and symptoms How your doctor will know if you have it Tests
More informationDifference between omeprazole and omeprazole delayed release
Cari untuk: Cari Cari Difference between omeprazole and omeprazole delayed release 7-2-2018 Easy to read patient leaflet for Omeprazole Delayed-Release Capsules. Includes indications, proper use, special
More informationIntroductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs
Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Dopaminergic Drugs: Actions Symptoms of parkinsonism are caused by depletion of dopamine in CNS Amantadine: makes more of dopamine available
More informationDigestion. Text. What You Don t Know Can Hurt You!
Digestion Text What You Don t Know Can Hurt You! Digestive Problems Approximately 36.5 million visits annually to ambulatory care facilities due to the diseases of the digestive system Over 4 million ulcers
More informationQUICK QUERIES. Topical Questions, Sound Answers
QUICK QUERIES Topical Questions, Sound Answers Dyspepsia: An Evidence-Based Approach Alan B. R. Thomson, MD, PhD, FRCPC, FACP, FACG Presented at the University of Alberta s Medical Grand Rounds, University
More informationDOMPERIDONE BNF 4.6. Domperidone is a dopamine type 2-receptor antagonist. It is structurally related to the
DOMPERIDONE BNF 4.6 Class: Prokinetic anti-emetic. Indications: Nausea and vomiting, dysmotility dyspepsia, gastro-oesophageal reflux. Pharmacology Domperidone is a dopamine type 2-receptor antagonist.
More informationTherapeutic Agents for the Gastrointestinal System
Therapeutic Agents for the Gastrointestinal System Chapter 20 1 Form and Function of the Gastrointestinal System There are three main functions of the gastrointestinal (GI) system: Digestion Absorption
More informationWeek 12 - Outline. Outline. Digestive System I Major Organs. Overview of Digestive System
Outline Week 12 - Digestive System I Major Organs Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Digestive Tract Function GI Tract Structure Regulation of the
More informationGastrointestinal Physiology
Gastrointestinal Physiology Digestion and Absorption Definition Digestion: i Food dis dissolved d and broken down. Physical digestion: Propulsion and mixing of food by muscle in the alimentary tract. Chemical
More informationMEDICATION GUIDE Lansoprazole (lan-so-pruh-zole) Delayed-release Capsules, USP
MEDICATION GUIDE Lansoprazole (lan-so-pruh-zole) Delayed-release Capsules, USP Read this Medication Guide before you start taking lansoprazole delayed-release capsules and each time you get a refill. There
More informationManagement of dyspepsia and of Helicobacter pylori infection
Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia
More informationASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER
European Medicines Agency Evaluation of Medicines for Human Use London, October 2007 Doc. Ref. EMEA/527934/2007 ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER The Paediatric Working Party
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. rabeprazole sodium tablets
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr RABEPRAZOLE EC rabeprazole sodium tablets Read this carefully before you start taking RABEPRAZOLE EC and each time
More informationPART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. Pantoprazole Magnesium Enteric-Coated Tablets
PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE Pr PANTOPRAZOLE T Pantoprazole Magnesium Enteric-Coated Tablets Read this carefully before you start taking
More informationOmeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty.
Omeprazole 10mg Name, Restriction, Manner of administration and form omeprazole 10 mg enteric tablet, 30 (8332M) Gastro-oesophageal reflux disease Name, Restriction, Manner of administration and form omeprazole
More informationMY PATIENT HAS READ THAT HIS PPI S MAY BE TROUBLE. NOW WHAT?
MY PATIENT HAS READ THAT HIS PPI S MAY BE TROUBLE. NOW WHAT? Clarence Wong MD FRCPC Associate Professor FACULTY/PRESENTER DISCLOSURE Faculty: Clarence Wong Relationships with commercial interests: Grants/Research
More information